I
Ian D. Pavord
Researcher at University of Oxford
Publications - 654
Citations - 55329
Ian D. Pavord is an academic researcher from University of Oxford. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 108, co-authored 575 publications receiving 47691 citations. Previous affiliations of Ian D. Pavord include John Radcliffe Hospital & University of Warwick.
Papers
More filters
Journal ArticleDOI
Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma
Chris Newby,Joshua Agbetile,Beverley Hargadon,Will Monteiro,Ruth H. Green,Ian D. Pavord,Christopher E. Brightling,Salman Siddiqui +7 more
TL;DR: The amplitude of sputum eosinophilia was associated with postbronchodilator FEV₁ in asthmatic patients and high variability rather than the amplitude at baseline or over time of spUTum eOSinophils wasassociated with accelerated FEV ₁ decrease.
Journal ArticleDOI
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
William W. Busse,Sally E. Wenzel,Thomas B. Casale,J. Mark FitzGerald,Megan S. Rice,Nadia Daizadeh,Yamo Deniz,Naimish Patel,Sivan Harel,Paul Rowe,Neil M.H. Graham,Thomas G. O'Riordan,Ian D. Pavord +12 more
TL;DR: In this article, the authors assessed the added prognostic value of baseline fractional exhaled nitric oxide (FeNO) to blood eosinophil count and prior severe asthma exacerbations for subsequent exacerbations.
Journal ArticleDOI
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Ruth H. Green,Christopher E. Brightling,S McKenna,B Hargadon,N Neale,D Parker,C Ruse,Ian P. Hall,Ian D. Pavord +8 more
TL;DR: In this paper, the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids, were compared.
Journal ArticleDOI
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol
Ian D. Pavord,Peter K. Jeffery,Yusheng Qiu,Jie Zhu,Debbie Parker,Åsa Carlsheimer,Ian Naya,Neil Barnes +7 more
TL;DR: In this article, the effects of budesonide/formoterol 200/6 μg twice daily plus as-needed with Budesonide/Formoterol 800/12 μg twice a day on airway eosinophils and remodeling were compared with higher fixed-dose combination regimens.
Journal ArticleDOI
Obstructive sleep apnoea: a cause of chronic cough.
Surinder S. Birring,Alvin J. Ing,Kevin Chan,Gavina Cossa,Sérgio Matos,Mike Morgan,Ian D. Pavord +6 more
TL;DR: 4 patients presenting with an isolated chronic cough who were subsequently found to have obstructive sleep apnoea are reported, and the cough improved rapidly with nocturnal continuous positive airway pressure therapy.